Metformin

nuclear factor kappa B subunit 1 ; Homo sapiens







38 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34844106 Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application. 2022 Jan 1
2 35496297 Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells. 2022 2
3 33524789 The effects of metformin on autophagy. 2021 May 1
4 34163481 Metformin, Macrophage Dysfunction and Atherosclerosis. 2021 1
5 34895136 Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K/AKT pathway in an AMPK dependent way. 2021 Dec 11 2
6 34911941 Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma. 2021 Dec 15 1
7 32004509 Metformin rescues Parkin protein expression and mitophagy in high glucose-challenged human renal epithelial cells by inhibiting NF-κB via PP2A activation. 2020 Apr 1 2
8 32258978 Caspase recruitment domain family member 9 expression is a promising biomarker in esophageal squamous cell carcinoma. 2020 Mar 2
9 33014814 Metformin Overcomes Acquired Resistance to EGFR TKIs in EGFR-Mutant Lung Cancer via AMPK/ERK/NF-κB Signaling Pathway. 2020 3
10 33184242 High-glucose-induced apoptosis, ROS production and pro-inflammatory response in cardiomyocytes is attenuated by metformin treatment via PP2A activation. 2020 2
11 30520054 Metformin inhibits pro-inflammatory responses via targeting nuclear factor-κB in HaCaT cells. 2019 Jan 5
12 30628691 Protective effects of metformin on lipopolysaccharide‑induced airway epithelial cell injury via NF‑κB signaling inhibition. 2019 Mar 4
13 30754072 NF-κB as the mediator of metformin's effect on ageing and ageing-related diseases. 2019 May 1
14 30765814 Metformin inhibits lithocholic acid-induced interleukin 8 upregulation in colorectal cancer cells by suppressing ROS production and NF-kB activity. 2019 Feb 14 2
15 30845774 Abdominal Fat SIRT6 Expression and Its Relationship with Inflammatory and Metabolic Pathways in Pre-Diabetic Overweight Patients. 2019 Mar 6 1
16 31337349 Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways. 2019 Jul 23 2
17 29396886 Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma. 2018 Apr 4
18 29630425 Suppressive effects of metformin on T-helper 1-related chemokines expression in the human monocytic leukemia cell line THP-1. 2018 Nov 3
19 29772687 Metformin Induces Apoptosis and Alters Cellular Responses to Oxidative Stress in Ht29 Colon Cancer Cells: Preliminary Findings. 2018 May 16 2
20 30009823 Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation. 2018 Sep 1 1
21 30097812 Anti-inflammatory Action of Metformin with Respect to CX3CL1/CX3CR1 Signaling in Human Placental Circulation in Normal-Glucose Versus High-Glucose Environments. 2018 Dec 1
22 30307719 Metformin synergistically enhances the antitumor activity of the third-generation EGFR-TKI CO-1686 in lung cancer cells through suppressing NF-κB signaling. 2018 Dec 1
23 28159472 Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs. 2017 Mar 1 1
24 29147073 Metformin Suppressed CXCL8 Expression and Cell Migration in HEK293/TLR4 Cell Line. 2017 2
25 27246734 Metformin preconditioning provide neuroprotection through enhancement of autophagy and suppression of inflammation and apoptosis after spinal cord injury. 2016 Sep 2 1
26 27424158 Exenatide and metformin express their anti-inflammatory effects on human monocytes/macrophages by the attenuation of MAPKs and NFκB signaling. 2016 Oct 2
27 27706018 Controls of Nuclear Factor-Kappa B Signaling Activity by 5'-AMP-Activated Protein Kinase Activation With Examples in Human Bladder Cancer Cells. 2016 Sep 1
28 25772174 Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect. 2015 2
29 26141671 Metformin ameliorates the proinflammatory state in patients with carotid artery atherosclerosis through sirtuin 1 induction. 2015 Nov 4
30 26391700 Serum levels of TSP-1, NF-κB and TGF-β1 in polycystic ovarian syndrome (PCOS) patients in northern China suggest PCOS is associated with chronic inflammation. 2015 Dec 1
31 24243637 Proinflammatory cytokine induction of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) in human adipocytes is mediated by MEK, C/EBPβ, and NF-κB/RelA. 2014 Jan 1
32 25674239 Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-κB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options. 2014 1
33 23277563 Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth. 2013 Jan 15 3
34 23510106 Metformin: a case of divide and conquer. 2013 Mar 11 1
35 23521863 Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation. 2013 Jun 5
36 20852028 Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. 2010 Dec 1
37 16385087 Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. 2006 Mar 3
38 15983226 Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. 2005 Jul 1